Tuomo Puhakka, MDa, Mika J

Slides:

Advertisements

Similar presentations

W.Travis Cain, MDa, Greg Cable, PhDb, John J. Oppenheimer, MDc

Advertisements

Pulmonary abnormalities in patients with primary hypogammaglobulinemia

Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis Fuad M. Baroody, MD, David Brown, MD,

Double-blind placebo-controlled study of the efficacy of oral terfenadine in the treatment of chronic fatigue syndrome Paul Steinberg, MDa, Bruce E.

Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy Monica B. Arvidsson, MD, Olle.

Kiwi fruit allergy: A new birch pollen–associated food allergy

Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.

Sinusitis in the common cold

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Human rhinovirus in bronchial epithelium of infants with recurrent respiratory symptoms Kristiina Malmström, MD, PhD, Anne Pitkäranta, MD, PhD, Olli Carpen,

The effects of upper respiratory infection on T-cell proliferation and steroid sensitivity of asthmatics Elcio O. Vianna, MD, PhD, Jay Westcott, PhD,

A review of the preclinical and clinical data of newer intranasal steroids used in the treatment of allergic rhinitis William R. Lumry, MD Journal of.

Kiwi fruit allergy: A new birch pollen–associated food allergy

A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children Mark Boguniewicz, MDa, Virginia C. Fiedler,

Fluticasone furoate nasal spray reduces the nasal-ocular reflex: A mechanism for the efficacy of topical steroids in controlling allergic eye symptoms

Two randomized, double-blind, placebo-controlled studies of fluticasone propionate lotion 0.05% for the treatment of atopic dermatitis in subjects from.

Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg, and placebo in the treatment of seasonal allergic rhinitis Paul H. Ratner,

Sinusitis in the common cold

Practice Notes from the AAAI

Badrul A. Chowdhury, MD, PhD

Hydroxychloroquine improves airflow and lowers circulating IgE levels in subjects with moderate symptomatic asthma B.Lauren Charous, MD, Elkan F. Halpern,

Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis James.

As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis Albert Jen, MD, Fuad Baroody, MD, Marcy de Tineo,

Edwin A. Bronsky, MD, Howard Druce, MD, Steven R. Findlay, MD, Frank C

Adverse effects of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors associated with elevated serum IgE and eosinophilia Carol K. Fosso, MDa,

Product characteristics and pharmacokinetics of intranasal ipratropium bromide Chester C. Wood, MDa, Philip Fireman, MDb, Jay Grossman, MDc, Margaret.

Harold B. Kaiser, MDa, Steven R. Findlay, MD†, John W

Comparison of a nasal glucocorticoid, antileukotriene, and a combination of antileukotriene and antihistamine in the treatment of seasonal allergic rhinitis

Elephantiasis nostras: A case report

Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis Fuad M. Baroody, MD, David Brown, MD,

Low-dose fluticasone propionate compared with montelukast for first-line treatment of persistent asthma: A randomized clinical trial William Busse, MDa,

Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with.

Conjunctivitis medicamentosa

Efficacy and safety of budesonide inhalation suspension (Pulmicort Respules) in young children with inhaled steroid–dependent, persistent asthma Gail.

Practice Notes from the AAAAI

Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic.

Effect of acetazolamide on cough induced by low-chloride-ion solutions in normal subjects: Comparison with furosemide Antonio Foresi, MD, Giampaolo Cavigioli,

A dose-ranging study of the efficacy and safety of azelastine nasal spray in the treatment of seasonal allergic rhinitis with an acute model John M.

Robert A. Wood, MD, Wanda Phipatanakul, MD, Robert G

A review of the current guidelines for allergic rhinitis and asthma

Physician-targeted program on inhaled therapy for childhood asthma

News & Notes Journal of Allergy and Clinical Immunology

Correlation between alcohol-induced asthma and acetaldehyde dehydrogenase-2 genotype Atsuko Takao, MDa, Terufumi Shimoda, MDa, Shigeru Kohno, MDa, Sadahiro.

James P. Kemp, MDa, David A. Cook, MDb, Gary A

Salmeterol and fluticasone propionate combined in a new powder inhalation device for the treatment of asthma: A randomized, double-blind, placebo-controlled.

Efficacy of nebulized budesonide in treatment of severe infantile asthma: A double-blind study Jacques de Blic, MDa, Christophe Delacourt, MDa, Muriel.

The Editors' Choice Journal of Allergy and Clinical Immunology

Salmeterol resolves airway obstruction but does not possess anti-eosinophil efficacy in newly diagnosed asthma: A randomized, double-blind, parallel group.

Subjective and objective assessments in patients with seasonal allergic rhinitis: Effects of therapy with mometasone furoate nasal spray Eli O. Meltzer,

F.Estelle R. Simons, MDa, Bruce M. Prenner, MDb, Albert Finn, MDc

Vascular endothelial growth factor in patients with acute asthma

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma Gordon D. Raphael, MDa, Robert.

News & Notes Journal of Allergy and Clinical Immunology

Fluticasone propionate powder: Oral corticosteroid–sparing effect and improved lung function and quality of life in patients with severe chronic asthma

Low-dose inhaled fluticasone propionate versus oral zafirlukast in the treatment of persistent asthma Eugene R. Bleecker, MDa, Michael J. Welch, MDb,

Occupational allergy caused by urticating hair of Brazilian spider

Omalizumab improves asthma-related quality of life in patients with severe allergic asthma Albert Finn, MDa, Gary Gross, MDb, Julius van Bavel, MDc,

The 30th anniversary of the American Board of Allergy and Immunology: Then and now Lynn Des Prez a, Charles E. Reed, MD, Lawrence B. Schwartz, MDb, John.

A prospective, controlled study showing that rubber gloves are the major contributor to latex aeroallergen levels in the operating room Dann K. Heilman,

Practice Notes from the AAAI

Anaphylaxis after initial ingestion of rambutan, a tropical fruit

Tuomo Puhakka, MDa, Mika J

Footnotes1 Journal of Allergy and Clinical Immunology

Macrolide antibiotics and asthma treatment

Larry C. Borish, MDa, Harold S

Evelyn Farinas, RPh, MGA, Peter Honig, MD

Quantification of conjunctival vascular reaction by digital imaging

Asthma symptoms and airway hyperresponsiveness are lower during treatment with nedocromil sodium than during treatment with regular inhaled albuterol

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial Eli O. Meltzer, MDa,

News & Notes Journal of Allergy and Clinical Immunology

Presentation transcript:

The common cold: Effects of intranasal fluticasone propionate treatment Tuomo Puhakka, MDa, Mika J. Mäkelä, MD a,b, Kristiina Malmström, MDa, Matti Uhari, MDc, Johannes Savolainen, MDa,b, Erkki O. Terho, MDb, Markku Pulkkinen, RNd, Olli Ruuskanen, MDa Journal of Allergy and Clinical Immunology Volume 101, Issue 6, Pages 726-731 (June 1998) DOI: 10.1016/S0091-6749(98)70301-X Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 1 Frequency of respiratory symptoms by day ( n = 199). Dashed line, FP; solid line, placebo. Journal of Allergy and Clinical Immunology 1998 101, 726-731DOI: (10.1016/S0091-6749(98)70301-X) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 2 Resolution of respiratory symptoms (n = 199). Subjects were asked to score their symptoms from 0 to 3, with 0 referring to absence of symptoms. Rhinorrhea score was obtained by summing symptom scores of watery rhinitis and purulent rhinitis (scale of severity, 0 to 6). *Significance difference (p < 0.05, as determined by Wilcoxon test). Dashed line, FP; solid line, placebo. Journal of Allergy and Clinical Immunology 1998 101, 726-731DOI: (10.1016/S0091-6749(98)70301-X) Copyright © 1998 Mosby, Inc. Terms and Conditions

Fig. 3 Resolution of respiratory symptoms in culture-positive (dashed lines) and culture-negative (solid lines) subjects for S. pneumoniae, H. influenzae, or M. catarrhalis in the nasopharynx on day 1. Symptom score was obtained by summing the symptom scores of purulent rhinitis, sore throat, cough, and sputum (scale of severity, 0 to 12). *Significance difference (p < 0.05, as determined by the Wilcoxon test). Journal of Allergy and Clinical Immunology 1998 101, 726-731DOI: (10.1016/S0091-6749(98)70301-X) Copyright © 1998 Mosby, Inc. Terms and Conditions